Swiss Stocks Extend 19-Month High After US Jobs Report Bloomberg Lonza Group AG (LONN) slipped 2.6 percent to 49.29 francs. Lonza and Teva Pharmaceutical Industries Ltd. are still evaluating the path forward for a phase III trial of its rituximab generic drug based on the latest changes in the regulatory environment ... |
